• COVID-19
  • Simoa® Technology
  • Therapeutic Areas
    NeurologyOncologyImmunology/InflammationInfectious DiseaseCardiology
  • Products & Services
    Simoa® Assay KitsReady-to-use Simoa® assay kits compatible with Quanterix instrumentsSimoa® SARS CoV-2 Antigen Assay (EUA)COVID-19 antigen test for qualitative detection of N protein antigen and permitted for use under FDA Emergency Use AuthorizationHD-X Analyzer™Our flagship automated immunoassay analyzer offering ultrasensitive biomarker measurementSR-X™ Biomarker Detection SystemBenchtop digital immunoassay platform delivering ultrasensitive biomarker detection in a compact instrumentSP-X Imaging and Analysis System™Robust circulating biomarker detection in a benchtop multiplex immunoassay platform2470 ArrayerFully automated microarray printer powered by proprietary soft touch deposition technologySimoa® Accelerator LaboratoryFull-service center for biomarker testing services and custom immunoassay developmentUman NF-Light™NfL ELISA kits and antibodies for the detection of neurofilament light chainHomebrew – Custom Assay DevelopmentUltrasensitive immunoassay development solution providing flexibility for specialized research applications
  • Support & Resources
    Customer Care & Technical SupportSafety Data Sheets & Cert. of AnalysisProduct BrochuresWhitepapers & App NotesPublications And PostersConferencesWebinars
  • Media Center
    Press ReleasesVideos & RecordingsIn The NewsBlog
  • Company
    Meet the Management TeamMeet the Global Sales Team
  • Contact Us
  • Careers
  • Investors
  • Customer Portal
  • Search

stay tuned

Subscribe to our newsletter

info@quanterix.com

617 301 9400

900 Middlesex TPKE
Billerica, MA 01821
USA

  • Investor Portal
  • Customer Portal
  • Contact Us
  • Terms and Conditions
  • Privacy Shield Statement
© 2021 Quanterix All rights reserved.
  • Privacy Policy

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more